Hua Han

ORCID: 0000-0003-4713-4631 · 3 papers in corpus
other 2024
miR-375-3p predicts the severity of endometriosis and regulates cellular progression by targeting NOX4
Molecular and cellular probes ·doi:10.1016/j.mcp.2024.101999

BACKGROUND: Due to the complex pathogenesis of endometriosis, its early screening and development prediction are still challenging problems in the clinic. OBJECTIVES: This study evaluated the significance of miR-375-3p in endometriosis ons…

other 2023
Causal association between lipid-lowering drugs and female reproductive endocrine diseases: a drug-targeted Mendelian randomization study
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1295412

PURPOSE: The relationship between dyslipidemia and female reproductive endocrine diseases has been increasingly studied. The use of lipid-lowering drugs in treating various related diseases, including coronary heart disease, may affect fema…

other 2022
The effects of mifepristone on the structure of human decidua and chorion and Bax and Bcl-2 expression at early stage of pregnancy
BMC pharmacology & toxicology ·doi:10.1186/s40360-022-00592-4

BACKGROUND: As a progesterone receptor antagonist, mifepristone combined with misoprostol is widely used to terminate early pregnancy in clinical practice. It has also been reported that mifepristone may cause cell death in decidual cells a…